ArticleFrontiers in oncology2022

PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449.

Celimene Galiger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.